Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Status unconfirmed
Conditions studied: Prostate Cancer, Benign Prostatic Hypertrophy, Bladder Stones, Kidney Stones
In brief
This is a double-blind, study to evaluate the performance of NV-VPAC1 PCa Urine Diagnostic Test in three distinct populations being treated at the Intermountain Urology Clinic. The first population (positive control) is comprised of men with biopsy-confirmed PCa who are scheduled for prostatectomy. The second population (negative control) is comprised of men with benign prostatic hypertrophy (BPH) who are scheduled for transurethral resection of the prostate (TURP). The third population (negative control) is comprised of men or women with bladder/kidney stones who are scheduled for a cystoscopy.
Key facts
- Study ID
- NCT03630926
- Run by
- Intermountain Health Care, Inc.
- People needed
- 45
- Starts
- 2018-10-16
- Expected to finish
- 2019-12-01
- Last updated by the study team
- 2019-04-26
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males 18-80 years of age
- Biopsy-confirmed prostate cancer
- Scheduled within 2 weeks for prostatectomy
- Signed informed consent
You may not qualify if…
- Presence or history of another cancer diagnosis, with the exception of certain skin cancers
- Currently treated with finasteride (Proscar®, Propecia®), dutasteride (Avodart®) or anti-androgen therapy (Lupron®)
- Participated in a clinical study with an investigational drug within 2 weeks of the screening visit.
- Subjects with benign prostatic hypertrophy
- Inclusion Criteria:
- Males 18-80 years of age
- Diagnosis of BPH made by clinical symptoms (e.g., enlarged prostate, dribbling urine stream, frequent and urgent urination)
- Scheduled within 2 weeks for TURP
- Signed informed consent
- Exclusion Criteria:
- Presence or history of any cancer diagnosis, with the exception of certain skin cancers
- Currently treated with finasteride (Proscar®, Propecia®) or dutasteride (Avodart®)
- Participated in a clinical study with an investigational drug within 2 weeks of the screening visit.
- Subjects with bladder/kidney stones
- Inclusion Criteria:
- Males or females 18-80 years of age
- Diagnosed with bladder/kidney stones
- Scheduled within 2 weeks for cystoscopy
- Signed informed consent
- Exclusion Criteria:
- Presence or history of any cancer diagnosis, with the exception of certain skin cancers
- Participated in a clinical study with an investigational drug within 2 weeks of the screening visit.
Where it is running
- Intermountain Medical Center — Murray, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.